morphine sulfate
Generic: morphine sulfate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
morphine sulfate
Generic Name
morphine sulfate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
morphine sulfate 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-452
Product ID
63323-452_dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA204223
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2018-04-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323452
Hyphenated Format
63323-452
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
morphine sulfate (source: ndc)
Generic Name
morphine sulfate (source: ndc)
Application Number
NDA204223 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 BOX (63323-452-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-452-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc", "openfda": {"upc": ["0363323454005", "0363323451004"], "unii": ["X3P646A2J0"], "rxcui": ["1731993", "1732006", "1732011", "1732136", "2003714"], "spl_set_id": ["582f42e5-444e-4246-af8c-e7e28097c69a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 BOX (63323-452-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-452-00)", "package_ndc": "63323-452-01", "marketing_start_date": "20180410"}], "brand_name": "Morphine Sulfate", "product_id": "63323-452_dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "63323-452", "dea_schedule": "CII", "generic_name": "Morphine Sulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Morphine Sulfate", "active_ingredients": [{"name": "MORPHINE SULFATE", "strength": "2 mg/mL"}], "application_number": "NDA204223", "marketing_category": "NDA", "marketing_start_date": "20180410", "listing_expiration_date": "20261231"}